Search Results - "Guzelkas, I."

P172 CFTR Modulators in children with cystic fibrosis: real-life evidence in Turkey by Guzelkas, I., Alboga, D., Erdal, M.A., Demir, H.I., Atan, R., Yavuz, B.C., Buyuksahin, H.N., Sunman, B., Yalcin, E., Emiralioglu, N., Dogru, D., Kiper, N., Ozcelik, U.

Get full text

P166 Losses in the gains of children with cystic fibrosis who had to interrupt their modulator therapies by Capraz, B., Yalcin, E., Buyuksahin, H. Nayir, Sunman, B., Guzelkas, I., Alboga, D., Erdal, M. Akgul, Demir, H.I., Atan, R., Emiralioglu, N., Dogru, D., Ozcelik, U., Kiper, N.

Get full text

The airway microbiota in siblings with primary ciliary dyskinesia: related factors and correlation with clinical characteristics by Tural, D. Ademhan, Kasikci, M., Altay, Özlem, Polat, S. Eryilmaz, Ozsezen, B., Hizal, M., Sunman, B., Buyuksahin, H. Nayir, Guzelkas, I., Dolgun, T. Yuksel, Emiralioglu, N., Yalcin, E., Dogru, D., Kiper, N., Hascelik, G., Diker, K. S., Ozcelik, U.

Get full text

P314 Cystic fibrosis related to bone disease in children: can it be predicted? by Buyuksahin, H. Nayir, Dogru, D., Gözmen, O., Ozon, A., Portakal, O., Emiralioglu, N., Haliloglu, M., Kılıc, K., Yaglı, N. Vardar, Yıldırım, D., Dag, O., Guzelkas, I., Yalcin, E., Ozcelik, U., Kiper, N.

Get full text

EPS1.06 Galectin-3: potential biomarkers in children with cystic fibrosis by Tural, D. Ademhan, Emiralioglu, N., Akin, S., Alboga, D., Ozsezen, B., Buyuksahin, H. Nayir, Guzelkas, I., Sunman, B., Gungor, I., Yalcın, E., Dogru, D., Kiper, N., Demirel, A.H., Ozcelik, U.

Get full text

P219 Otorhinolaryngologic, audiological and genetic findings in children with cystic fibrosis: a tertiary care experience by Büyükşahin, H. Nayır, Yalcın, E., Gökırmak, İ., Ertugrul, G., Erden, D. Dayangaç, Sennaroglu, G., Ozer, S., Akkaplan, S., Yesil, I.E., Guzelkas, I., Sunman, B., Alboga, D., Erdal, M. Akgul, Demir, İ., Atan, R., Capraz, B., Emiralioglu, N., Dogru, D., Ozcelik, U., Kiper, N.

Get full text

P022 Evaluation of hearing and vestibular system in patients with cystic fibrosis by Ozsezen, B., Nabiyev, M., Ertuĝrul, G., Avci, H., Ademhan, D., Sunman, B., Nayir Buyuksahin, H., Guzelkas, I., Bajin, M.D., Dogru, D., Emiralioglu, N., Yalcin, E., Ozcelik, U., Kiper, N.

Get full text

P152 Clinical findings and long-term effect of methicillin-resistant Staphylococcus aureus isolation in patients with cystic fibrosis by Ozsezen, B., Dogru, D., Emiralioglu, N., Ademhan Tural, D., Sunman, B., Nayir Buyuksahin, H., Guzelkas, İ., Yalcın, E., Ozcelik, U., Kiper, N.

Get full text

P107 Coexistence of cystic fibrosis and metabolic disease: is this a related or coincidental condition? by Buyuksahin, H. Nayır, Emiralioĝlu, N., Sunman, B., Güzelkaş, İ., Alboĝa, D., Erdal, M. Akgül, Sivri, S., Yalcın, E., Doĝru, D., Özçelik, U., Kiper, N.

Get full text

P125 Impact of infection with Achromobacter spp. on clinical outcome in paediatric patients with cystic fibrosis by Sunman, B., Emiralioĝlu, N., Hazırolan, G., Tural, D.A., Özsezen, B., Nayir Büyükşahin, H., Güzelkaş, İ., Yalçın, E., Doĝru, D., Özçelik, U., Kiper, N.

Get full text

P115 Effectiveness of different eradication treatment protocols for the first Pseudomonas aeruginosa isolation in paediatric cystic fibrosis patients by Sunman, B., Emiralioĝlu, N., Ademhan Tural, D., Özsezen, B., Nayir Büyükşahin, H., Güzelkaş, İ., Yalçın, E., Doĝru, D., Özçelik, U., Kiper, N.

Get full text